377 related articles for article (PubMed ID: 2145171)
1. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
2. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
3. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
5. Murine thymic nurse cell clone supports the growth of fetal thymocytes in the presence of interleukin 2.
Doi H; Nakagawa S; Nagata K; Hata M; Kasahara S; Sakata T; Suzuki R; Nanno M; Sugamura K; Itoh T
Eur J Immunol; 1991 Mar; 21(3):783-92. PubMed ID: 1672648
[TBL] [Abstract][Full Text] [Related]
6. Comparison of interleukin 2 and 12-O-tetradecanoylphorbol 13-acetate as signals for protein kinase C activation in purified human T lymphocytes.
Mahé Y; Piau JP; Wakasugi N; Tursz T; Gacon G; Wakasugi H
Eur J Immunol; 1988 Dec; 18(12):2029-36. PubMed ID: 2975602
[TBL] [Abstract][Full Text] [Related]
7. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
9. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules.
Davis LS; Oppenheimer-Marks N; Bednarczyk JL; McIntyre BW; Lipsky PE
J Immunol; 1990 Aug; 145(3):785-93. PubMed ID: 1695644
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells.
Schwinzer R; Franklin RA; Domenico J; Renz H; Gelfand EW
J Immunol; 1992 Mar; 148(5):1322-8. PubMed ID: 1371524
[TBL] [Abstract][Full Text] [Related]
12. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 4 (BSF-1) induces growth in resting murine CD8 T cells triggered via cross-linking of T3 cell surface structures.
Miethke T; Schmidberger R; Heeg K; Gillis S; Wagner H
Eur J Immunol; 1988 May; 18(5):767-72. PubMed ID: 2967763
[TBL] [Abstract][Full Text] [Related]
14. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
15. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
Geppert TD; Lipsky PE
J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
[TBL] [Abstract][Full Text] [Related]
16. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
Lee HM; Rich S
J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
[TBL] [Abstract][Full Text] [Related]
19. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
Landis RC; Friedman ML; Fisher RI; Ellis TM
J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
Ceuppens JL; Baroja ML
J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]